Severe hepatic injury induced by carbamazepine associated with toxic epidermal necrolysis. Report of a case.
DOI:
https://doi.org/10.18041/2390-0512/bioc..1.2245Keywords:
Toxic epidermal necrolysis, Carbamazepine, EncephalopathyAbstract
Toxic epidermal necrolysis and Stevens Johnson syndrome are rare and fatal disorders, characterized by severe skin and mucosal injury. These disorders are the same condition, it is differentiated by the degree of affection of the total body surface. The hypersensitivity reaction of drugs is the most frequent etiology of these two entities; On the other hand, the liver is also a target of lesions caused by medications, which can lead to severe hepatitis and even worse acute liver failure, leading to jaundice, encephalopathy and coagulopathy. The present case is a patient suffering a head trauma with the presence of subdural hematoma, days after the start of consumption of carbamazepine as anticonvulsant prophylaxis and acetaminophen for pain, generating skin lesion that compromised more than 30% of the body surface, injury severe hepatic disease with marked elevation of transaminases and encephalopathy, which could well correspond to subdural hematoma or hepatic damage; This generated great interest.
Downloads
References
Kohanim S, Palioura S, et al. Steven Johnson Síndrome/Toxic Epidermal Necrolisis – A Comprensive Review and Guide to Therapy. The Ocular Surface. 2016; 14:1
Bastuji-Garin S, Berthold R, et al. Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erithema Multiforme. Archives of Dermatology. 1992;129
Schwartz R, McDonough P, et al. Toxic Epidermal Necrolysis. American Academy of Dermatology. 2016;69:173
Mockenhaupt M, Viboud C, et al. Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study. Journal of Investigative Dermatology. 2008;128:35-44
Mukasa Y, Craven N. Management of Toxic Epidermal Necrolysis and Related Syndromes. Posgraduate Medical Journal. 2008;84:60-65
Holt M, Ju C. Drug-induced liver injury. Handbook Experimental Pharmacology. 2010;196:3–27.
Yuan L, Kaplowitz N. Mechanisms of Drug-Induced Liver Injury. Clinics in Liver Disease. 2013; 17:507-518
Au J, Pockros P. Drug-Induced Liver Injury from Antiepileptic Drugs. Clinics in Liver Disease. 2013; 17:687-697.
Bover T, Manns M. Acute liver failure. Zakim & Boyer`s Hepatology: A textbook of liver disease. 6ª Edition. Elsevier, 2012.
Pirmohamed M, Leeder J. Anticonvulsivant Agents. Drug-Induced Liver Disease. 3° Edition. Elsevier, 2013.
Stricker BHC. Drug-Induced Hepatic Injury. Amsterdam. Elsevier Science Publishers. 1992.
Pellock JM. Carbamazepine Side Effects in Children and Adults. Epilepsia 1987; 28:S64-70.
Ye Y, Yu-Hor B, Park H. Hypersensitivity Antiepileptic Drug. Immunology and Allergy Clinics of North America. 2014; 633-643.
Bernal W, Wendon J. Acute Liver Failure. The New England Journal of Medicine. 2013;369:2525-34
Bunchorntavakul C, Rajender K. Acetaminophen-related Hepatotoxity. Clinics in Liver Disease. 2013;17:587-607
Cacoub P, Musette P, et al. The DRESS Syndrome: A Literature Review. The American Journal of Medicine. 2011;124:588-597
Patrick P, James N. Clinical and Neurologic Manifestation of Minimal Hepatic Encephalopathy and Overt Hepatic Encephalopathy. Clinics in Liver Disease. 2015;19:461-472